NUS Logo
Yong Loo Lin
School of Medicine

NUS Medicine researchers develop potential oral anti-diabetic drug

Published: 23 Oct 2016

newsinfomain daa1 231016Left to right: Associate Professor Teoh Yee Leong, Professor Lee Kok Onn, Associate Professor Sim Meng Kwoon. Photo credit: Singapore Clinical Research Institute (SCRI)

 1 in 9 Singaporeans suffer from diabetes today, and the number is set to grow from 400,000 in 2013, to 600,000 by 2030. After 20 years of research, NUS Medicine pharmacology researchers developed an oral anti-diabetic drug and have successfully completed Phase I clinical trial. The drug improves the action of insulin and reduces damaging chronic inflammation that accompanies diabetes.

 

News Coverage

Latest Updates